Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
RM 67.09
RM 6038.46RM 67.09
RM 804.71
60 tablet
Free AirMail shipping Hot
RM 71.57
RM 4293.95RM 71.57
RM 268.16
30 tablet
Free AirMail shipping Hot
RM 76.04
RM 2281.06RM 76.04
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
RM 80.51
RM 7246.20RM 80.51
RM 402.13
60 tablet
Free AirMail shipping Hot
RM 82.75
RM 4964.92RM 82.75
RM 133.97
30 tablet
Free AirMail shipping Hot
RM 84.98
RM 2549.44RM 84.98
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
RM 96.17
RM 8655.22RM 96.17
RM 402.13
60 tablet
Free AirMail shipping Hot
RM 98.40
RM 5904.27RM 98.40
RM 133.97
30 tablet
Free AirMail shipping Hot
RM 100.64
RM 3019.12RM 100.64
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.